SOLU-MEDROL 40 MG — DIN 02367947
METHYLPREDNISOLONE (METHYLPREDNISOLONE SODIUM SUCCINATE) : 40 MG · PFIZER CANADA ULC · KIT ; POWDER FOR SOLUTION · wholesale supply in Canada
Health Canada status: MARKETED
What is SOLU-MEDROL?
SOLU-MEDROL 40 MG contains METHYLPREDNISOLONE (METHYLPREDNISOLONE SODIUM SUCCINATE) : 40 MG. It is listed in the Health Canada Drug Product Database under DIN 02367947, held by PFIZER CANADA ULC, supplied as KIT ; POWDER FOR SOLUTION for INTRAVENOUS ; INTRAMUSCULAR administration. Health Canada currently lists it as marketed, status dated 11-Jan-2012. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is SOLU-MEDROL used for?
Hypersensitivity/dermatologic conditions (asthma, anaphylaxis, dermatitis); adjunctive therapy for SLE, rheumatic fever, gout; ulcerative colitis; shock; organ transplants; cerebral oedema.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
How much does Methylprednisolone cost around the world?
Methylprednisolone is listed on 7 of the national price registers Nexara ingests. Each country publishes on a different basis, so those figures are not comparable with one another — or with a Canadian wholesale price.
What a market publishes matters more than the number it publishes. Australia publishes a ex-manufacturer; Greece publishes a producer price (ex-factory); Morocco publishes a PPV (public price). Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.
| Market | Price basis published there | Brands | Packs listed | Range |
|---|---|---|---|---|
| Australia | ex-manufacturer | 9 | 61 | AUD███.██ |
| United States | acquisition | 8 | 32 | USD███.██ |
| Morocco | PPV (public price) | 5 | 18 | MAD███.██ |
| Saudi Arabia | public | 14 | 18 | SAR███.██ |
| South Africa | single exit price | 12 | 17 | ZAR███.██ |
| Greece | producer price (ex-factory) | 13 | 13 | EUR███.██ |
| United Arab Emirates | public | 1 | 1 | AED███.██ |
160 pack listings across 62 brand entries and 6 price bases, refreshed 08 Sep 2026. Ranges span every Methylprednisolone pack in that market, so a high figure is usually a larger pack rather than the same product.
Canada publishes no comparable public list price. For a delivered Canadian price on a licensed account, verify your licence — it takes about a minute.
Is there a generic Methylprednisolone in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
6 holders have a Canadian DIN containing Methylprednisolone, across 34 DINs, of which 13 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| PFIZER CANADA ULC | 19 | 13 | DEPO-MEDROL, MEDROL, SOLU-MEDROL | Sourceable in Canada |
| TEVA CANADA LIMITED | 5 | 0 | METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION | No marketed DIN |
| SANDOZ CANADA INCORPORATED | 4 | 0 | METHYLPREDNISOLONE ACETATE INJECTABLE SUSPENSION USP, METHYLPREDNISOLONE ACETATE INJECTABLE SUSPENSION USP -(80MG/ML WITH PRESERVATIVE), METHYLPREDNISOLONE ACETATE INJECTABLE SUSPENSION USP -(40MG/ML WITH PRESERVATIVE) | No marketed DIN |
| HOSPIRA HEALTHCARE ULC | 2 | 0 | METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION, USP | No marketed DIN |
| TARO PHARMACEUTICALS INC | 2 | 0 | TARO-METHYLPREDNISOLONE INJECTION | No marketed DIN |
| THE UPJOHN COMPANY OF CANADA | 2 | 0 | SOLUMEDROL INJ 125MG STERILE MIXOVIAL, SOLUMEDROL INJ 40MG STERILE MIXOVIAL | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 40 MG |
|---|---|
| Dosage form | KIT ; POWDER FOR SOLUTION |
| Route | INTRAVENOUS ; INTRAMUSCULAR |
| Pack configuration (monograph) | Plain Vials: 500 mg (pkg of 5), 1 g (pkg of 1). ACT-O-VIALS: 40 mg (pkg of 10), 125 mg (pkg of 10), 500 mg (pkg of 5), 1 g (pkg of 1). |
| Storage | Store reconstituted solution at room temperature (15-30°C). Use within 48 hours. Single dose vials; discard unused portion. |
Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
Substance and classification
| Active substance | Methylprednisolone |
|---|---|
| ATC code | H02AB04 |
| AHFS class | 68:04.00 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 02367947 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2367947 |
| Brand name | SOLU-MEDROL |
| Generic / active ingredient | METHYLPREDNISOLONE (METHYLPREDNISOLONE SODIUM SUCCINATE) : 40 MG |
| Market authorization holder | PFIZER CANADA ULC |
| Health Canada schedule | Prescription |
| ATC code | H02AB04 |
| ATC anatomical main group | H — Systemic hormonal preparations |
| ATC therapeutic subgroup | H02AB |
| Current status | MARKETED |
| Status date | 11-Jan-2012 |
| Original market date | 2012-01-11 00:00:00 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
How is it administered?
IV or IM injection/infusion. Life-threatening: 30 mg/kg IV over 30 min, repeat every 4-6 hours. Other: 10-500 mg IV. Ulcerative colitis: 40-120 mg as retention enema.
Included because it drives pack selection and wastage. Consult the monograph.
Contraindications
Hypersensitivity to ingredients (including cow's milk in 40mg); systemic fungal infections; live vaccines; intrathecal/epidural use; premature infants; idiopathic thrombocytopenic purpura (IM use).
Warnings and precautions
Risk of HPA axis suppression; avoid abrupt withdrawal. May mask infections or exacerbate fungal/viral/latent infections. Risk of GI perforation, hypertension, and pheochromocytoma crisis.
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
13 of 34 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| DEPO-MEDROL | 40 MG | SUSPENSION | PFIZER CANADA ULC | MARKETED | 01934333 |
| DEPO-MEDROL | 40 MG | SUSPENSION | PFIZER CANADA ULC | MARKETED | 00030759 |
| DEPO-MEDROL | 80 MG | SUSPENSION | PFIZER CANADA ULC | MARKETED | 01934341 |
| DEPO-MEDROL | 80 MG | SUSPENSION | PFIZER CANADA ULC | MARKETED | 00030767 |
| DEPO-MEDROL | 20 MG | SUSPENSION | PFIZER CANADA ULC | MARKETED | 01934325 |
| MEDROL | 16 MG | TABLET | PFIZER CANADA ULC | MARKETED | 00036129 |
| MEDROL | 4 MG | TABLET | PFIZER CANADA ULC | MARKETED | 00030988 |
| SOLU-MEDROL | 500 MG | POWDER FOR SOLUTION | PFIZER CANADA ULC | MARKETED | 00030678 |
| SOLU-MEDROL | 1 G | POWDER FOR SOLUTION | PFIZER CANADA ULC | MARKETED | 00036137 |
| SOLU-MEDROL | 125 MG | POWDER FOR SOLUTION ; KIT | PFIZER CANADA ULC | MARKETED | 02367955 |
2 · Same class — other molecules in ATC H02AB
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Dexamethasone | APO-DEXAMETHASONE · DECADRON PHOSPHATE INJ 4MG/ML · DECADRON TAB 0.5MG · DECADRON TAB 4MG · DEXAMETHASONE · DEXAMETHASONE OMEGA UNIDOSE · DEXAMETHASONE SOD PHOS INJ 4MG/ML · DEXAMETHASONE SOD PHOSPH INJ 10MG/ML USP · DEXAMETHASONE SODIUM PHOSPHATE INJ USP 4MG/ML · DEXAMETHASONE SODIUM PHOSPHATE INJECTION SDZ · DEXAMETHASONE SODIUM PHOSPHATE INJECTION, USP · DEXAMETHASONE UNIDOSE · DEXAMETHASONE-OMEGA · DEXASONE 0.5MG · DEXASONE 0.75MG · DEXASONE 4MG · DOM-DEXAMETHASONE TABLET 4MG · HEXADROL PHOSPHATE INJ 10MG/ML · HEXADROL PHOSPHATE INJ 4MG/ML · ODAN-DEXAMETHASONE ELIXIR · PHL-DEXAMETHASONE · PMS-DEXAMETHASONE · PMS-DEXAMETHASONE ELIXIR · PMS-DEXAMETHASONE SOD PHOSPHATE INJ 10MG/ML · PMS-DEXAMETHASONE SOD PHOSPHATE INJ 4MG/ML · PRO-DEXAMETHASONE - 4 · RATIO-DEXAMETHASONE · RATIO-DEXAMETHASONE TABLETS, USP | 42 | 13 | Yes |
| Methylprednisolone | DEPO-MEDROL · MEDROL · METHYLPREDNISOLONE ACETATE INJECTABLE SUSPENSION USP · METHYLPREDNISOLONE ACETATE INJECTABLE SUSPENSION USP -(80MG/ML WITH PRESERVATIVE) · METHYLPREDNISOLONE ACETATE INJECTABLE SUSPENSION USP -(40MG/ML WITH PRESERVATIVE) · METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION · METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION, USP · SOLU-MEDROL · SOLUMEDROL INJ 125MG STERILE MIXOVIAL · SOLUMEDROL INJ 40MG STERILE MIXOVIAL · TARO-METHYLPREDNISOLONE INJECTION | 34 | 13 | Yes |
| Hydrocortisone | A-HYDROCORT INJ 1000MG/8ML · A-HYDROCORT INJ 100MG/2ML · A-HYDROCORT INJ 250MG/2ML · A-HYDROCORT INJ 500MG/4ML · AURO-HYDROCORTISONE · CORTEF · HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION · HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION USP · HYDROCORTISONE SODIUM SUCCINATE INJECTION · SOLU-CORTEF | 18 | 8 | Yes |
| Prednisone | ALTI-PREDNISONE TAB 5MG · APO PREDNISONE TAB 1MG USP · APO PREDNISONE TAB 50MG · APO PREDNISONE TAB 5MG · DELTASONE 50MG · DELTASONE 5MG · JAA PREDNISONE TAB 1MG USP · JAA PREDNISONE TAB 50MG USP · JAA PREDNISONE TAB 5MG USP · NU-PREDNISONE · PREDNISONE 50 TAB 50MG · PREDNISONE TAB 5MG · TEVA-PREDNISONE · WINPRED · WINPRED TAB 5MG | 19 | 5 | Yes |
| Triamcinolone | ARISTOCORT - SYR ORL 0.4MG/ML · ARISTOCORT - TAB 4MG · ARISTOCORT FORTE - LIQ IA IM ISY 40MG/ML · ARISTOCORT FORTE INJ 40MG/ML · ARISTOCORT INJ INTRALESIONAL 25MG/ML · ARISTOCORT INJ INTRALESIONAL-25MG/ML · ARISTOCORT SYR 2MG/5ML · ARISTOCORT TAB 2MG · ARISTOCORT TAB 4MG · ARISTOCORT-TAB 2MG · ARISTOSPAN · ARISTOSPAN SUS 20MG/ML · KENALOG-10 INJECTION · KENALOG-40 INJECTION · SCHEINPHARM TRIAMCINE-A INJECT.SUS-40MG/ML · TRIAMCINOLONE ACETONIDE INJECTABLE SUSPENSION USP · TRIAMCINOLONE DIACETATE SUS 40MG/ML · TRIAMCINOLONE DIACETATE SUSPENSION · TRISPAN | 21 | 3 | Yes |
| Betamethasone | BETAJECT · BETNESOL TAB 0.5MG · BETNESOL TABLETS · CELESTONE REPETABS 1MG · CELESTONE SOLUSPAN · CELESTONE TAB 0.5MG | 6 | 1 | Yes |
| Prednisolone | NOVO-PREDNISOLONE 5MG · PEDIAPRED · PEDIAPRED - LIQ 6.7MG/5ML · PMS-PREDNISOLONE | 4 | 1 | Yes |
| Cortisone | CORTISONE ACETATE · CORTONE SUS 50MG/ML · CORTONE TAB 25MG · CORTONE TAB 5MG | 4 | 1 | Yes |
| Prednisone, Combinations | METRETON TAB | 1 | 0 | Not in Canada |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC H02A
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| H02AA | Fludrocortisone | 3 | 2 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
What else is SOLU-MEDROL called?
The same molecule, Methylprednisolone, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| Advantan | Latin | Australia |
| METHYLPREDNISOLONE MYLAN | Latin | Morocco |
| Advantan (Fatty) | Latin | Australia |
| Metvant | Latin | Australia |
| Metvant (Fatty) | Latin | Australia |
| Supriad Cream | Latin | Australia |
| Supriad Fatty Ointment | Latin | Australia |
| Supriad Ointment | Latin | Australia |
| Tanilone (Fatty) | Latin | Australia |
| SOLU MEDROL | Latin | Morocco |
| Depo-Medrol | Latin | Australia |
| MEDROL | Latin | Morocco |
| Ap Methylpred | Latin | South Africa |
| DEPO MEDROL | Latin | Morocco |
| Medrolone | Latin | Saudi Arabia |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.